Vir Biotechnology, INC.

Clinical Stage immunology company

Based in CA

🤖

AI Overview

With $1.6M in lobbying spend across 22 quarterly filings, Vir Biotechnology, INC. is a significant lobbying presence. They deploy 15 individual lobbyists

$1.6M
Total Lobbying Spend
22
Quarterly Filings
1
Lobbying Firms Used
15
Individual Lobbyists

Spending by Year

YearLobbying Spend
2020$270K
2021$340K
2022$320K
2023$310K
2024$150K
2025$200K

Lobbying Firms

FORBES-TATE

What They Lobby For

  • Healthcare initiatives related to novel antibody technology platform.
  • Issues related to H.R. 925 - The Heroes Act.
  • Healthcare initiatives related to novel antibody technology platform; Issues related to COVID funding; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
  • Issues related to COVID funding.
  • Healthcare initiatives related to novel antibody technology platform; Issues related to COVID funding.
  • Issues related to research and development tax credit.
  • Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products.

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.